Press Releases

07/01/2019 Achievement of two major development milestones pdf
 
 
31/12/2018 Biom’up raises €3 million from the €10 million credit line granted in March 2018 by Athyrium pdf
 
 
12/06/2018 Biom’up successfully closes a €7.67 million private placement financing pdf
 
 
12/05/2018 Biom’up launches a private placement financing of a minimum of €7 million pdf
 
 
11/28/2018 Biom’up sees a strong commercial uptake in HEMOBLASTTM Bellows in the US and Europe pdf
 
 
11/08/2018 Biom’up announces completion of the 2018 scale-up of its manufacturing facility to meet commercial demand for HEMOBLASTTM Bellows pdf
 
 
10/18/2018 Reinforcement of management’s participation in the Company’s share capital pdf
 
 
10/16/2018 Biom’up announces a first distribution agreement in Europe and the filing of a reimbursement dossier with Australian health authorities pdf
 
 
09/13/2018 H1 2018 results on track with the company’s business plan pdf
 
 
09/04/2018 Biom’up completes its Board of Directors with the nomination of Dr. Peter Byloos to support its international growth pdf
 
 
07/25/2018 Biom’up present at the 8th Strategic Council of Health Industries hosted by France’s Prime Minister pdf
 
 
07/12/2018 Biom’up obtains CE Mark for its HEMOBLASTTM Bellows Laparoscopic Applicator pdf
 
 
07/03/2018

Biom’up announces first sales of HEMOBLASTTM Bellows in the United States and the nomination to its board of directors of an independent director and an observer to support the company’s growth

pdf
 
 
05/02/2018 Biom’up finalizes U.S. commercial organization to support U.S. launch of HEMOBLASTTM Bellows pdf
     
04/24/2018 Biom’up has trained 200 surgeons in the US and in Europe ahead of HEMOBLAST Bellows™ launch pdf
 
 
04/16/2018 Biom'up reports 2017 full-year results  and provides corporate update pdf
 
 
04/03/2018 Biom’up and Athyrium close first tranche of bond financing for €25 million with stock warrants attached pdf
 
 
03/26/2018 Biom’up Appoints Thierry Darnis as Global Vice President, Manufacturing & Engineering pdf
 
 
03/06/2018

Biom’up announces the construction of a new production plant and the creation of 150 jobs in Lyon Metropole

pdf
 
 
02/20/2018 Biom'up completes the first of its financing operations for a total amount of more than €40 million pdf
 
 
02/14/2018 Biom’up announces a financing targeting a total of €43m pdf
 
 
01/22/2018 Summary of Biom'Up's liquidity contract with CM-CIC Market Solutions (in French) pdf
 

 
 
12/18/2017 Biom’up receives FDA marketing approval for HEMOBLASTTM Bellows, its flagship product pdf
 
 
12/13/2017 Biom’up to be included in the Euronext’s CAC® Small, CAC® Mid & Small and CAC® All-Tradable indexes pdf
 
 
12/06/2017 Biom’up appoints Cécile Ferracci as Global Vice President Marketing pdf
 
 
11/09/2017 Biom’up confirms the success of its IPO. Over-allotment option partially exercised pdf
     
10/27/2017 Biom’up provides regulatory update regarding HEMOBLAST™ Bellows pdf
 
 
10/11/2017 Biom’up announces the success of its IPO, raising close to €38.1 million on Euronext Paris pdf
 
 
09/26/2017 Biom’up launches its IPO on the Euronext regulated market in Paris pdf
 
 
09/12/2017 Filing of the document de Base pdf